Kevin J Yeaman sold $4.7M of DLB
President and CEO at Dolby Laboratories, Inc.. 57,888 shares at an average of $80.49, traded Nov 25, 2024, filed Nov 27, 2024.
Score components
- +25RoleCEO
- +25Trade size$4.7M at market
- +10Share of holdings soldSold 43% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-131633, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | MOption exercise Class A Common Stockindirect: By a trust10b5-1 | +50,000 | $62.32 | $3.1M | 133,721 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Class A Common Stockindirect: By a trust10b5-1 | -49,104 | $80.53 | $4.0M | 84,617 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Class A Common Stockindirect: By a trust10b5-1 | -896 | $81.18 | $73k | 83,721 | Nov 27, 2024 |
| Nov 26, 2024 | MOption exercise Class A Common Stockindirect: By a trust10b5-1 | +7,888 | $62.32 | $492k | 91,609 | Nov 27, 2024 |
| Nov 26, 2024 | SOpen-market sale Class A Common Stockindirect: By a trust10b5-1 | -7,888 | $80.19 | $633k | 83,721 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Employee Stock Option (Right to Buy)derivativeindirect: By a trust10b5-1 | -50,000 | $0.00 | $0 | 7,888 | Nov 27, 2024 |
| Nov 26, 2024 | MOption exercise Employee Stock Option (Right to Buy)derivativeindirect: By a trust10b5-1 | -7,888 | $0.00 | $0 | 0 | Nov 27, 2024 |
Related signals
Other insiders at Dolby Laboratories, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $451k 7,667 shares | -4% | |
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $468k 7,667 shares | -6% | |
| 13Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $500k 7,273 shares | -6% | |
| 31Weak | DLBsell Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $408k 6,164 shares | -5% | |
| 20Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $1.8M 25,000 shares | -18% | |
| 41Moderate | Dolby Laboratories, Inc. | Shriram Revankar SVP, Advanced Technology Group | $524k 7,000 shares | -9% | |
| 28Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $1.8M 25,000 shares | -18% | |
| 25Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $3.2M 42,366 shares | -27% | |
| 20Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $1.9M 25,000 shares | -18% | |
| 28Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $2.6M 33,683 shares | -23% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.